10.01.15
Allergan plc, has received approval from the U.S. FDA to market Juvederm Ultra XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21.
"As the leader in medical aesthetics, Allergan is committed to continued research and development in this area," said Philippe Schaison, EVP & president, Allergan Medical. "With this approval, Juvederm Ultra XC is now the only filler that is approved to last up to one year in the lips while providing natural-looking results."
Juvederm formulations were first approved in the US in 2006.
"As the leader in medical aesthetics, Allergan is committed to continued research and development in this area," said Philippe Schaison, EVP & president, Allergan Medical. "With this approval, Juvederm Ultra XC is now the only filler that is approved to last up to one year in the lips while providing natural-looking results."
Juvederm formulations were first approved in the US in 2006.